ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year.Incremental Payments Received ...
Biotech Companies’ Q3 Updates: Promising Cancer Treatments on the Horizon
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As many biotech companies within the oncology space begin to roll out their ...
EuropaWire22h
Alder Hey Secures £1.1M NIHR Funding to Boost Pediatric Health Research in Partnership with University of Liverpool
(IN BRIEF) Alder Hey Children’s NHS Foundation Trust has secured £1.1 million from the NIHR to upgrade its advanced 3T ...